BNSO yields 44.64% · JNJ yields 2.13%● Live data
📍 BNSO pulled ahead of the other in Year 1
Combined, BNSO + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BNSO + JNJ for your $10,000?
Bonso Electronics International Inc., together with its subsidiaries, designs, develops, produces, and sells electronic sensor-based and wireless products. It operates in four segments: Scales, Pet Electronic Products, Rental and Management, and Others. The Scales segment provides sensor-based scales products that include bathroom, kitchen, office, jewelry, laboratory, postal, and industrial scales for consumer, commercial, and industrial applications. The Pet Electronic Products segment develops and produces pet-related electronic products for use in consumer applications. The Rental and Management segment offers leasing of factories and machineries to third parties. The Others segment sells cordless leaf blowers, food vacuum sealers, and hydroponics growing systems, as well as scrap materials; and provides tooling and molding charges for scales. It serves private label original equipment, original brand manufacturers, and original design manufacturers primarily in the United States, Germany, and the People's Republic of China. The company also sells its pet electronic products through online platforms. The company was formerly known as Golden Virtue Limited and changed its name to Bonso Electronics International Inc. in September 1988. Bonso Electronics International Inc. was incorporated in 1988 and is based in Tsim Sha Tsui, Hong Kong.
Full BNSO Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.